Planned Solutions Inc. acquired a new position in The Procter & Gamble Company (NYSE:PG – Free Report) during the fourth quarter, HoldingsChannel reports. The fund acquired 3,916 shares of the company’s stock, valued at approximately $574,000.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Wyrmwood Management LLC bought a new stake in Procter & Gamble in the fourth quarter valued at about $29,000. Itau Unibanco Holding S.A. bought a new stake in shares of Procter & Gamble in the second quarter worth about $50,000. CGC Financial Services LLC acquired a new position in shares of Procter & Gamble during the second quarter worth about $55,000. VitalStone Financial LLC acquired a new position in shares of Procter & Gamble during the second quarter worth about $60,000. Finally, RVW Wealth LLC acquired a new position in shares of Procter & Gamble during the third quarter worth about $77,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Trading Up 1.3 %
Shares of PG opened at $162.61 on Thursday. The firm has a market cap of $382.62 billion, a price-to-earnings ratio of 27.24, a PEG ratio of 3.28 and a beta of 0.44. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $162.74. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.44 and a current ratio of 0.64. The business’s fifty day moving average is $158.17 and its 200-day moving average is $152.09.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Friday, January 19th were paid a dividend of $0.9407 per share. This represents a $3.76 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date of this dividend was Thursday, January 18th. Procter & Gamble’s dividend payout ratio (DPR) is currently 62.98%.
Insider Buying and Selling
In other news, CEO R. Alexandra Keith sold 776 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the sale, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider Marc S. Pritchard sold 101,704 shares of the firm’s stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $153.57, for a total value of $15,618,683.28. Following the completion of the transaction, the insider now directly owns 163,428 shares of the company’s stock, valued at $25,097,637.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the transaction, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The disclosure for this sale can be found here. In the last three months, insiders have sold 279,063 shares of company stock valued at $43,187,745. 0.17% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on the company. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Royal Bank of Canada increased their price target on Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 24th. Wells Fargo & Company increased their price target on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research report on Wednesday, January 24th. Barclays upped their price objective on Procter & Gamble from $160.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. Finally, Truist Financial upgraded Procter & Gamble from a “hold” rating to a “buy” rating and upped their price objective for the company from $160.00 to $175.00 in a research note on Monday, March 11th. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $168.41.
Check Out Our Latest Research Report on PG
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
See Also
- Five stocks we like better than Procter & Gamble
- What is the Euro STOXX 50 Index?
- Krispy Kreme’s Sweet Deal: McDonald’s Partnership Sparks Growth?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Bitcoin Depot Falls Into Value Territory With Expansion Underway
- Why Invest in 5G? How to Invest in 5G Stocks
- 7 Stocks That Will Drive the Weight Loss Drugs Market
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.